A comparison of Alberta’s Infant Motor Scale and Brazelton Neonatal Behavior Assessment Scale

Perera, P.; Godamunne, P.; Nandasena, S.; Tipre, M.; Wimalasiri, U.; Leader, M.; Beddage, T.; Smith, T.; Kasturiratne, A.; Sathiakumar, N.; Wickremesighe, R.

doi:10.1101/462572

bioRxiv · 10.1101/462572

A comparison of Alberta’s Infant Motor Scale and Brazelton Neonatal Behavior Assessment Scale

Perera, P.·Godamunne, P.·Nandasena, S.·Tipre, M.·Wimalasiri, U.·Leader, M.·Beddage, T.·Smith, T.·Kasturiratne, A.·Sathiakumar, N.·Wickremesighe, R.

View original source ↗Export metadata ↓

Abstract

Background and aims: The Neonatal Behavior Assessment Scale (NBAS) was introduced by Brazelton is a useful tool to assess neurodevelopment in newborn in research setting. However, it is complex, time-consuming and requires specialized training for administration and is therefore difficult tool to use in routine clinical settings. The Alberta Infant Motor Scale (AIMS) is a simple tool to assess of motor maturation of a child up to 18 months and can be administered with minimal training for the health care professionals. The study goal of this study was to evaluate the reliability and validity of the AIMS in comparison with the NBAS in assessing motor maturity at birth. Methods: We administered the AIMS and NBAS to a total of 66 newborn babies delivered in three obstetric units at the Colombo North Teaching Hospital in Ragama, Sri Lanka. The subjects were selected from a sample of 545 newborn babies in an ongoing birth-cohort study evaluating effects of prenatal exposure to biomass smoke and infant neurodevelopment. Trained research assistants administered first the NBAS, followed by the AIMS one-hour later. Univariate and bivariate statistics were used to compare the two scales. Results: Irrespective of maturity, sex, birth weight or socio-demographic characteristics, all babies had scored on the 75th percentile in the AIMS. In the NBAS, there was a significant variation in the Brazelton motor score scaled to 100. Low birth weight babies showed a narrower variation in the NABS score. None of the scales indicated a motor deficit in any of the children. Conclusion: NBAS identifies subtle differences in motor maturity of full term babies that the AIMS fails to detect.

Explore related subjects

neuroscience Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Perera, P., Godamunne, P., Nandasena, S., Tipre, M., Wimalasiri, U., Leader, M., Beddage, T., Smith, T., Kasturiratne, A., Sathiakumar, N., Wickremesighe, R.. 2018-11-05. A comparison of Alberta’s Infant Motor Scale and Brazelton Neonatal Behavior Assessment Scale. https://doi.org/10.1101/462572

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗